Nanalysis Scientific Salute del bilancio

Salute finanziaria criteri di controllo 2/6

Nanalysis Scientific ha un patrimonio netto totale di CA$24.2M e un debito totale di CA$14.7M, che porta il suo rapporto debito/patrimonio netto a 61%. Le sue attività totali e le sue passività totali sono rispettivamente CA$51.5M e CA$27.3M.

Informazioni chiave

61.0%

Rapporto debito/patrimonio netto

CA$14.75m

Debito

Indice di copertura degli interessi	n/a
Contanti	CA$1.13m
Patrimonio netto	CA$24.17m
Totale passività	CA$27.29m
Totale attività	CA$51.45m

Aggiornamenti recenti sulla salute finanziaria

Recent updates

Is Nanalysis Scientific (CVE:NSCI) Using Too Much Debt?

Oct 28

Nanalysis Scientific Corp.'s (CVE:NSCI) CEO Will Probably Find It Hard To See A Huge Raise This Year

Jun 19

Nanalysis Scientific Corp. (CVE:NSCI) Stock Catapults 29% Though Its Price And Business Still Lag The Industry

May 12

Benign Growth For Nanalysis Scientific Corp. (CVE:NSCI) Underpins Stock's 25% Plummet

Mar 24

Nanalysis Scientific Corp. (CVE:NSCI) Shares Fly 43% But Investors Aren't Buying For Growth

Feb 08

We Think Nanalysis Scientific (CVE:NSCI) Has A Fair Chunk Of Debt

Jan 31

Would Nanalysis Scientific (CVE:NSCI) Be Better Off With Less Debt?

Aug 26

Nanalysis Scientific Corp.'s (CVE:NSCI) Price Is Right But Growth Is Lacking

Apr 17

Is Nanalysis Scientific (CVE:NSCI) Using Too Much Debt?

Dec 08

Is Nanalysis Scientific (CVE:NSCI) Weighed On By Its Debt Load?

Jul 15

Health Check: How Prudently Does Nanalysis Scientific (CVE:NSCI) Use Debt?

Jan 24

Is Nanalysis Scientific (CVE:NSCI) Using Debt Sensibly?

Mar 29

Nanalysis Scientific (CVE:NSCI) Has Debt But No Earnings; Should You Worry?

Dec 14

Analisi della posizione finanziaria

Passività a breve termine: Le attività a breve termine ( CA$17.7M ) di NSCI superano le sue passività a breve termine ( CA$12.5M ).

Passività a lungo termine: Le attività a breve termine di NSCI ( CA$17.7M ) superano le sue passività a lungo termine ( CA$14.8M ).

Storia e analisi del rapporto debito/patrimonio netto

Livello di debito: Il rapporto debito netto/patrimonio netto ( 56.4% ) di NSCI è considerato alto.

Riduzione del debito: Il rapporto debito/patrimonio netto di NSCI è aumentato da 7.6% a 61% negli ultimi 5 anni.

Bilancio

Analisi della pista di contanti

Per le società che in passato sono state mediamente in perdita, valutiamo se hanno almeno un anno di liquidità.

Pista di liquidità stabile: NSCI ha meno di un anno di cash runway in base al suo attuale free cash flow.

Previsione Cash Runway: NSCI ha meno di un anno di liquidità disponibile se il flusso di cassa libero continua a ridursi ai tassi storici del 37.8 % ogni anno

Nanalysis Scientific Salute del bilancio

Salute finanziaria criteri di controllo 2/6

Informazioni chiave

Aggiornamenti recenti sulla salute finanziaria

Is Nanalysis Scientific (CVE:NSCI) Using Too Much Debt?

We Think Nanalysis Scientific (CVE:NSCI) Has A Fair Chunk Of Debt

Would Nanalysis Scientific (CVE:NSCI) Be Better Off With Less Debt?

Is Nanalysis Scientific (CVE:NSCI) Using Too Much Debt?

Is Nanalysis Scientific (CVE:NSCI) Weighed On By Its Debt Load?

Health Check: How Prudently Does Nanalysis Scientific (CVE:NSCI) Use Debt?

Recent updates

Nanalysis Scientific Corp. to Report Q3, 2024 Results on Nov 21, 2024

Is Nanalysis Scientific (CVE:NSCI) Using Too Much Debt?

Second quarter 2024 earnings released: CA$0.02 loss per share (vs CA$0.039 loss in 2Q 2023)

Nanalysis Scientific Corp. to Report Q2, 2024 Results on Aug 28, 2024

High number of new and inexperienced directors

Nanalysis Scientific Corp.'s (CVE:NSCI) CEO Will Probably Find It Hard To See A Huge Raise This Year

First quarter 2024 earnings released: CA$0.02 loss per share (vs CA$0.042 loss in 1Q 2023)

Nanalysis Scientific Corp. to Report Q1, 2024 Results on May 29, 2024

Nanalysis Scientific Corp. (CVE:NSCI) Stock Catapults 29% Though Its Price And Business Still Lag The Industry

Full year 2023 earnings released: CA$0.16 loss per share (vs CA$0.098 loss in FY 2022)

Nanalysis Scientific Corp., Annual General Meeting, Jun 26, 2024

Nanalysis Scientific Corp. to Report Q4, 2023 Results on Apr 25, 2024

Nanalysis Scientific Corp. Announces Resignation of Kham Lin as A Director

Nanalysis Corp. Receives Funding Supporting AI Software Development for Detection of Illicit Substances

Benign Growth For Nanalysis Scientific Corp. (CVE:NSCI) Underpins Stock's 25% Plummet

Nanalysis Scientific Corp. has completed a Composite Units Offering in the amount of CAD 5 million.

Nanalysis Scientific Corp. announced that it expects to receive CAD 1 million in funding

Nanalysis Scientific Corp. (CVE:NSCI) Shares Fly 43% But Investors Aren't Buying For Growth

Nanalysis Scientific Corp. Provides Earnings Guidance for the Fourth Quarter 2023

We Think Nanalysis Scientific (CVE:NSCI) Has A Fair Chunk Of Debt

Third quarter 2023 earnings released: CA$0.06 loss per share (vs CA$0.026 loss in 3Q 2022)

Nanalysis Scientific Corp. to Report Q3, 2023 Results on Nov 29, 2023

Would Nanalysis Scientific (CVE:NSCI) Be Better Off With Less Debt?

Second quarter 2023 earnings released: CA$0.04 loss per share (vs CA$0.024 loss in 2Q 2022)

Nanalysis Scientific Corp. to Report Q2, 2023 Results on Aug 24, 2023

Nanalysis Scientific Corp. to Report Q1, 2023 Results on May 25, 2023

Nanalysis Scientific Corp. announced that it has received CAD 4.1287 million in funding

Full year 2022 earnings released: CA$0.10 loss per share (vs CA$0.025 loss in FY 2021)

Nanalysis Scientific Corp.'s (CVE:NSCI) Price Is Right But Growth Is Lacking

Is Nanalysis Scientific (CVE:NSCI) Using Too Much Debt?

Third quarter 2022 earnings released

Nanalysis Scientific Corp. to Report Q3, 2022 Results on Nov 29, 2022

Price target decreased to CA$2.75

High number of new and inexperienced directors

Nanalysis Scientific Corp. Provides Revenue Guidance for the Third Quarter Ended September 30, 2022

Price target decreased to CA$2.75

Nanalysis Scientific Corp. to Report Q2, 2022 Results on Aug 25, 2022

Nanalysis Scientific Corp. Announces Executive Changes

Is Nanalysis Scientific (CVE:NSCI) Weighed On By Its Debt Load?

Nanalysis Scientific Corp. Announces Appointment of Kham Lin as New Director

First quarter 2022 earnings released: CA$0.017 loss per share (vs CA$0.007 loss in 1Q 2021)

Nanalysis Scientific Corp. to Report Q1, 2022 Results on May 31, 2022

Full year 2021 earnings released: CA$0.03 loss per share (vs CA$0.056 loss in FY 2020)

High number of new and inexperienced directors

Nanalysis Scientific Corp. to Report Fiscal Year 2021 Results on Apr 28, 2022

Nanalysis Scientific Corp. has completed a Follow-on Equity Offering in the amount of CAD 10.725 million.

Health Check: How Prudently Does Nanalysis Scientific (CVE:NSCI) Use Debt?

Nanalysis Scientific Corp. (TSXV:NSCI) completed the acquisition of K'(Prime) Technologies Inc.

Nanalysis Scientific Corp. announced that it expects to receive CAD 0.2025 million in funding

High number of new and inexperienced directors

Third quarter 2021 earnings released: CA$0.01 loss per share (vs CA$0.017 loss in 3Q 2020)

Second quarter 2021 earnings released

Nanalysis Scientific Corp. has completed a Composite Units Offering in the amount of CAD 8.00004 million.

Nanalysis Scientific Corp. announced that it has received CAD 1.797638 million in funding

First quarter 2021 earnings released: CA$0.007 loss per share (vs CA$0.014 loss in 1Q 2020)

Full year 2020 earnings released: CA$0.056 loss per share (vs CA$0.03 loss in FY 2019)

Is Nanalysis Scientific (CVE:NSCI) Using Debt Sensibly?

Nanalysis Scientific Corp. Signs Strategic OEM Partnership for Magnetic Resonance Electronics Sales

New 90-day high: CA$0.50

Nanalysis Scientific (CVE:NSCI) Has Debt But No Earnings; Should You Worry?

Third quarter 2020 earnings released: CA$0.017 loss per share

New 90-day low: CA$0.40

New 90-day low - CA$0.45

Earnings released

Analisi della posizione finanziaria

Storia e analisi del rapporto debito/patrimonio netto

Bilancio

Analisi della pista di contanti

Scoprire le aziende sane